PLXS.NASDAQPlexus CORP

Form 4: Plexus Exec. VP & CFO Sells PLXS Stock Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Plexus Corp.'s Executive Vice President and CFO, Patrick John Jermain, sold 2,178 shares of common stock for $130.42 per share under a pre-arranged 10b5-1 trading plan.

Summary

  • Patrick John Jermain, Executive Vice President and Chief Financial Officer of Plexus Corp. (PLXS), reported a transaction on August 6, 2025.
  • Jermain disposed of 2,178 shares of Plexus Corp. common stock.
  • The shares were sold at a price of $130.42 per share.
  • This transaction was conducted pursuant to a Rule 10b5-1(c) trading plan, indicating it was pre-scheduled.
  • Following this transaction, Jermain directly beneficially owns 23,459 shares of common stock.
  • Additionally, Jermain indirectly beneficially owns 3,719 shares of common stock through the Plexus Corp. 401(k) Retirement Plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the disclosure that it was conducted under a Rule 10b5-1 plan suggests it was a pre-planned event for personal financial management rather than a reaction to new company-specific information.

Negatives

  • An insider sale, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the insider's direct stake in the company.

Future Outlook

This filing is a disclosure of an insider stock transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details a routine insider transaction under a pre-arranged trading plan, which is common practice for executives managing their personal finances and equity compensation. It does not provide broader insights into industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: The sale by a key executive could be interpreted by some as a slight negative signal, though the 10b5-1 plan mitigates this concern. The overall impact on shareholder confidence is likely minimal given the routine nature of such disclosures.

Key Dates

DateDescription
08/06/2025Date of transaction (sale of common stock).
08/08/2025Date the Form 4 filing was signed and filed.

Keywords

Plexus Corp, PLXS, Insider Trading, Form 4, Stock Sale, Executive Compensation, 10b5-1 Plan, Patrick John Jermain, CFO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.